Susan H Wei
Overview
Explore the profile of Susan H Wei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
418
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Carroll Jr E, Wei S, Nagel G, Ruibal R
Dev Growth Differ
. 2023 Jun;
33(1):37-43.
PMID: 37282244
Eggs and cleavage-stage embryos of the frog Lepidobatrachus laevis are encased by 3 μm thick vitelline/fertilization envelope and two jelly layers, termed J (innermost) and J (outermost). Based on light...
2.
Wei S, Balch C, Paik H, Kim Y, Baldwin R, Liyanarachchi S, et al.
Clin Cancer Res
. 2006 May;
12(9):2788-94.
PMID: 16675572
Purpose: Aberrant DNA methylation, now recognized as a contributing factor to neoplasia, often shows definitive gene/sequence preferences unique to specific cancer types. Correspondingly, distinct combinations of methylated loci can function...
3.
Chan M, Wei S, Wen P, Wang Z, Matei D, Liu J, et al.
Clin Cancer Res
. 2005 Oct;
11(20):7376-83.
PMID: 16243810
Purpose: Repetitive ribosomal DNA (rDNA) genes are GC-rich clusters in the human genome. The aim of the study was to determine the methylation status of two rDNA subunits, the 18S...
4.
Leu Y, Yan P, Fan M, Jin V, Liu J, Curran E, et al.
Cancer Res
. 2004 Nov;
64(22):8184-92.
PMID: 15548683
Alterations in histones, chromatin-related proteins, and DNA methylation contribute to transcriptional silencing in cancer, but the sequence of these molecular events is not well understood. Here we demonstrate that on...
5.
Yan P, Wei S, Huang T
Methods Mol Biol
. 2004 Jul;
287:251-60.
PMID: 15273417
The methylation-specific oligonucleotide (MSO) microarray is a high-throughput approach capable of detecting DNA methylation in genes across several CpG sites. Based on the bisulfite modification of DNA that converts unmethylated...
6.
Leu Y, Rahmatpanah F, Shi H, Wei S, Liu J, Yan P, et al.
Cancer Res
. 2003 Oct;
63(19):6110-5.
PMID: 14559786
Small interfering RNAs (siRNAs) are newly identified molecules shown to silence genes via targeted mRNA degradation. In this study, we used specific siRNAs as a tool to probe the relationship...
7.
Chen C, Chen H, Hsiau T, Hsiau A, Shi H, Brock G, et al.
Am J Pathol
. 2003 Jun;
163(1):37-45.
PMID: 12819009
Hypermethylation of multiple CpG islands is a common event in cancer. To assess the prognostic values of this epigenetic alteration, we developed Methylation Target Array (MTA), derived from the concept...
8.
Shi H, Wei S, Leu Y, Rahmatpanah F, Liu J, Yan P, et al.
Cancer Res
. 2003 May;
63(9):2164-71.
PMID: 12727835
We developed a novel microarray system to assess gene expression, DNA methylation, and histone acetylation in parallel, and to dissect the complex hierarchy of epigenetic changes in cancer. An integrated...
9.
Wei S, Brown R, Huang T
Ann N Y Acad Sci
. 2003 May;
983:243-50.
PMID: 12724229
Epigenetic regulation of gene expression has been observed in a variety of tumor types. We have used microarray technology to evaluate the predisposition of drug response by aberrant methylation in...
10.
Yan P, Chen C, Shi H, Rahmatpanah F, Wei S, Huang T
J Nutr
. 2002 Aug;
132(8 Suppl):2430S-2434S.
PMID: 12163706
Differential methylation hybridization (DMH) is a high-throughput microarray technique designed to identify changes in DNA methylation patterns commonly observed in cancer and other disease states. The DMH methodology comprises three...